Dr. Linardic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-620-4467
Education & Training
- Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1999 - 2001
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1998 - 1999
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1995 - 1998
- Duke University School of MedicineClass of 1995
Certifications & Licensure
- NC State Medical License 1999 - 2025
- PA State Medical License 1996 - 2000
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group.Jamie M Aye, Wei Xue, Zhengya Gao, Matthew Ladra, Daniel J Indelicato
Pediatric Blood & Cancer. 2025-03-19 - Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sapna Oberoi, Frank M Balis
Cancer. 2024-11-15 - 4 citationsSpontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice.Peter G Hendrickson, Kristianne M Oristian, MaKenna R Browne, Lixia Luo, Yan Ma
Oncogene. 2024-04-01
Journal Articles
- Soft Tissue Sarcoma Cancer Stem Cells: An OverviewCorinne M Linardic, Katia C Genadry, Frontiers in Neurology
- Proceedings of the Fifth International RASopathies Symposium: When Development and Cancer IntersectDavid A Stevenson, Katherine A Rauen, Bruce D Gelb, Corinne M Linardic, Suma Shankar, Brigitte C Widemann, Karen Gripp, Maxim Itkin, American Journal of Medical Genetics Part A
Press Mentions
- Precision Genomics Collaboratory Graduate Student Pilot Grants AnnouncedAugust 3rd, 2021
Grant Support
- Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar RhabdomyosarcomaMASSACHUSETTS INSTITUTE OF TECHNOLOGY2024–2029
- Duke Center for Advancement of Child Health (CAtCH)DUKE UNIVERSITY2021–2026
- Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative ModelsDUKE UNIVERSITY2023–2025
- Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative ModelsDUKE UNIVERSITY2023–2025
- Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative ModelsDUKE UNIVERSITY2023–2025
- Screening for Cys-Reactive Ligands to Target PAX3-FOXO1DUKE UNIVERSITY2022–2025
- Screening for Cys-Reactive Ligands to Target PAX3-FOXO1DUKE UNIVERSITY2022–2025
- Screening for Cys-Reactive Ligands to Target PAX3-FOXO1DUKE UNIVERSITY2022–2025
- Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcomaDUKE UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: